The new age of clinical trials
In our last public lecture for 2020, we will unpack the art of clinical trials and reveal what the new age of trials means for you.
This year has been like no other with COVID propelling clinical trials to the front of our news channels on a daily basis and making them part of our everyday conversations.
Join Dr Tina Soulis, CEO of the Florey’s own clinical Contract Research Organisation (CRO),Neuroscience Trials Australia, to learn all about the world of clinical trials and the work being carried out in Australia and globally.
This lecture will also dispel the myths around clinical trials and help the audience to understand what the processes of clinical trials are, what it means to be involved in a clinical trial and the terminology used, with a special emphasis on trials related to brain disorders.
We will also be joined by Claire Cuddy who will unpack human patient-derived stem cells. She will explore how we can move from a patient sample through to a “brain in a dish” model to study the pathogenesis of neurological disease and develop new treatments.
Meet the Speakers
Dr Tina Soulis is considered an industry thought leader and Australian international advocate for clinical trials. She contributes to and is a pivotal member on many Australian and international clinical trial advocacy, policy and neurology focused leadership groups.
Over the past 9 years, Tina has built up Neuroscience Trials Australia, a leading global specialised brand making Australia a destination for many overseas companies wanting to undertake neurology focused clinical research. This Contract Research Organisation (CRO) is globally unique and offers clients access to clinical trial sites, expertise and capabilities required to complete clinical development at global standard. Prior to her role with Neuroscience Trials Australia, Tina was the director of clinical development at Acrux Pharma Pty Ltd, a successful Australian ASX200 biotechnology company. Tina led the strategic direction, development, co-ordination and reporting of the company’s clinical programs. Tina had pivotal involvement in taking a product right through all stages of clinical development and in submission of the product dossier for US regulatory approval and subsequent out-licensing of the product to one of the world’s largest pharmaceutical companies.
Tina is an expert driver of clinical drug development, particularly in the design, management and implementation of clinical trials and has worked as a clinical researcher and in senior roles within the pharmaceutical and biotechnology industry for over 25 years. Her experience encompasses all stages of drug and device development in many therapeutic areas and geographical regions.
Claire Cuddy manages the human stem cell laboratory in the Ion Channels and Human Disease Laboratory of Professor Steven Petrou and the Epilepsy Functional Genomics Laboratory of Associate Professor Snezana Maljevic.
Claire completed her Bachelor of Biomedicine (Honours) at The University of Melbourne in 2011 and since then has worked as a research assistant in human stem cells and modelling of neurological development and disease. Claire supports the workflow from patient sample to stem cells to disease modelling in a dish for the Petrou and Maljevic laboratories at The Florey.
Your support is vital in helping to uncover the secrets of our minds. If you'd like to make a contribution to our research please visit our donation page.
How can I contact the organiser with any questions?
Tel: 1800 063 693
Signup to our email newsletter to receive regular Florey updates
Brain health affects all Australians. You can support our research by making a donation or a bequest.